Epidemiology of pediatric obstructive sleep apnea

Julie C Lumeng1, Ronald D Chervin

  • 1Center for Human Growth and Development, and Department of Pediatrics, University of Michigan, Ann Arbor, MI 48109-0406, USA. jlumeng@umich.edu

Insights

Pediatric obstructive sleep apnea (OSA) affects many children, with prevalence ranging from 1% to 4%. Research highlights challenges in diagnosing sleep-disordered breathing (SDB) in kids.

Area of Science:

  • Pediatric Sleep Medicine
  • Epidemiology
  • Respiratory Medicine

Background:

  • Pediatric obstructive sleep apnea (OSA) is increasingly recognized as a significant childhood health issue.
  • Epidemiology and clinical features of pediatric OSA differ from adult OSA.
  • The spectrum of pediatric sleep-disordered breathing (SDB) ranges from primary snoring to OSA.

Purpose of the Study:

  • To systematically review studies on the epidemiology of pediatric SDB.
  • To identify methodologic challenges in pediatric SDB research.
  • To estimate the population prevalence of pediatric SDB and OSA.

Main Methods:

  • Systematic review of studies on pediatric SDB and OSA epidemiology.
  • Analysis of data on snoring, apneic events, and diagnostic criteria.
  • Meta-analysis of parent-reported snoring prevalence.

Main Results:

  • Estimated prevalence of habitual snoring: 1.5% to 6%.
  • Estimated prevalence of parent-reported apneic events: 0.2% to 4%.
  • Estimated prevalence of SDB (questionnaire-based): 4% to 11%.
  • Estimated prevalence of OSA (diagnostic criteria-based): 1% to 4%.
  • Overall snoring prevalence (meta-analysis): 7.45%.
  • SDB appears more common in boys, heavier children, and possibly African American children.

Conclusions:

  • Methodologic variability presents challenges in pediatric SDB/OSA epidemiology.
  • Prevalence estimates for pediatric SDB and OSA vary widely due to differing diagnostic criteria.
  • Future research should address these methodologic limitations to better understand pediatric SDB epidemiology.

Related Concept Videos

Sleep Apnea01:21

Sleep Apnea

Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...